Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate Tablet
Product Images NDC 0406-8020

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate (NDC 0406-8020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Specgx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 1

HCI stands for Human-Computer Interaction. It is a field of study that deals with the design, evaluation, and implementation of interactive computing systems for human use. The goal of HCI is to improve the interaction between users and computers by making interfaces more intuitive, user-friendly and efficient. This involves studying how people use technology and incorporating that knowledge into the design of software and hardware systems. Potential applications of HCI include the development of new interfaces for virtual reality, mobile devices, and gaming consoles.*

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 2

The text "HCl ¢ 2H,0" is not readable.*

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 3

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 4

NDC 0406-8005-03 is a prescription medication called Buprenorphine and Naloxone. It is available in sublingual tablet form with each tablet containing 2mg of Buprenorphine and 0.5mg of Naloxone. The medication is dispensed in 30 tablets and should be stored at controlled room temperature. The package insert should be consulted for full prescribing information. The product should be kept out of reach of children to avoid accidental ingestion. A guide should be given to each patient. The manufacturer is SpecGrLLC with a location at Webster Groves, MO 63119 USA.*

FDA Label Image

Buprenorphine HCl And Naloxone HCl Dihydrate Subli 5

This is a description of a drug containing Buprenorphine and Naloxone in tablet form. It is only available with a prescription and comes with a medication guide, which should be provided to each patient. Accidental intake by children requires emergency medical care, and the drug needs to be kept out of children's reach. The tablets should be stored in controlled room temperature between 20 to 25°C. Specific details about the drug's dosages can be found in the package insert. This drug was manufactured by SpecGLLC in the USA.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.